SensitivityThe minimum detectable dose of human IGLC2 is typically less than 0.078 ng/ml. The sensitivity of this assay, or Lower Limit of Detection (LLD) was defined as the lowest protein concentration that could be differentiated from zero. It was determined the m
Intended UseHuman IGLC2 ELISA Kit allows for the in vitro quantitative determination of IGLC2 , concentrations in serum, Plasma , tissue homogenates and Cell culture supernates and Other biological fluids.
StorageStore the whole ELISA kit at 4℃
Product Description specificalPrinciple of the assay: This assay employs the quantitative sandwich enzyme immunoassay technique. Antibody specific for IGLC2 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any IGLC2 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for IGLC2 is added to the wells. After washing, avidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of IGLC2 bound in the initial step. The color development is stopped and the intensity of the color is measured.
Human Ig lambda-2 chain C regions Protein information
P0CG05; A0M8Q4; P80423;
Human Ig lambda-2 chain C regions Protein SEQUENCE